Weight Loss Tips
Paying for Weight Loss Treatment in Instalments
A single large upfront cost is a genuine barrier for many people considering weight loss treatment. Here is how instalme...
In most cases, no. Weight management is typically treated as a lifestyle expense rather than a medical one, and excluded accordingly.
That framing is increasingly out of step with the evidence, but it is the reality you are dealing with. This covers why, what may still be claimable, and how to ask in a way that gets a useful answer.
The standard exclusion
Health insurance policies commonly exclude:
- Weight loss medication
- Bariatric and weight loss surgery
- Dietitian and nutrition consultations for weight
- Gym membership and fitness programmes
- Cosmetic procedures, which weight loss is often grouped with
The reasoning insurers apply is that obesity results from lifestyle choices and therefore falls outside the scope of insurable medical events.
Corporate group policies, which cover a large share of insured people in Pakistan, follow the same pattern in most cases.
Why that reasoning is outdated
The exclusion rests on a view of obesity as a behavioural failing rather than a medical condition. That view has not survived the evidence.
WHO's obesity fact sheet sets out how excess weight raises the risk of type 2 diabetes, heart disease, several cancers and musculoskeletal disorders. It is a driver of exactly the conditions insurers spend most treating.
The SELECT trial, published in 2023, followed adults with obesity and existing cardiovascular disease but without diabetes. Semaglutide reduced major adverse cardiovascular events compared with placebo.
That is a weight loss drug demonstrating reduced heart attacks and strokes. It is difficult to characterise as cosmetic.
The economic logic also points the other way. Treating obesity is generally cheaper than treating decades of its consequences. Insurers in several countries have begun revising coverage for exactly that reason, though change has been slow and uneven.
What is often covered
The distinction that matters in practice is between treating obesity and treating its complications.
Complications are usually covered:
- Type 2 diabetes management, including medication
- Hypertension treatment
- Cardiac investigation and treatment
- Sleep apnea investigation and CPAP in some policies
- Joint problems and orthopaedic care
- Fatty liver investigation
This creates an awkward situation. A policy may pay for diabetes medication for years while refusing to fund treatment that could reduce the diabetes.
There is an important nuance here. Ozempic and Mounjaro are approved for type 2 diabetes. If you have diabetes and are prescribed one for glucose control, that is a diabetes indication rather than a weight loss one, and coverage may be considered on that basis. Wegovy and Zepbound, approved for weight management, generally are not.
This is exactly why manufacturers maintain two brands for the same molecule.
The Pakistani complication
There is a barrier here that does not exist elsewhere.
No GLP-1 medication is registered in Pakistan. Not semaglutide, not tirzepatide, not liraglutide.
An insurer will not reimburse an unregistered medication obtained through informal import. There is no invoice from a licensed local supplier, no registration to reference and no prescribing pathway to validate.
So even where a policy might theoretically cover a diabetes indication, the practical route to a claim frequently does not exist for these drugs.
Bariatric surgery is different. It is performed at licensed hospitals with proper documentation, so a claim is at least possible even if usually declined.
How to ask properly
Asking "do you cover weight loss?" gets a reflexive no. More specific questions get more useful answers.
Ask about the indication, not the goal. "Is [medication] covered when prescribed for type 2 diabetes?" is a different question from "do you cover weight loss drugs?"
Ask for the exclusion in writing. Request the specific clause. Vague verbal refusals are sometimes wrong.
Ask about bariatric surgery separately, particularly with a BMI of 40 or above or 35 with serious comorbidity. Some policies treat surgery for morbid obesity differently from weight management generally.
Ask about the complication. Investigation and treatment of sleep apnea, fatty liver or diabetes may be covered even when weight treatment is not.
Get your doctor to document medical necessity. A letter setting out the conditions being treated and the clinical rationale is more persuasive than a request framed around weight.
Check corporate policies specifically. Employer schemes sometimes include wellness benefits that are not obvious in the standard documentation.
If you are self-funding
Which most people in Pakistan will be, for the reasons above.
The cost arithmetic then matters more, not less. Imported GLP-1 injections run Rs 20,000 to Rs 50,000 monthly, plus consultation, cold chain and monitoring, across a course of 56 to 72 weeks based on trial durations.
Self-funding that is beyond most households, which is why the question of what is obtainable and sustainable becomes the practical one.
Lupin Life's METASLIM™ is structured for self-funding rather than reimbursement. Physician review is built into the programme price rather than charged as a separate consultation, delivery is included with cash on delivery, and it is manufactured to GMP standards. It is a physician-reviewed sublingual supplement rather than a pharmaceutical GLP-1 receptor agonist, and it does not produce injectable trial results.
The relevant point for this article is that it does not depend on a reimbursement pathway that does not exist here.
If you want to discuss your situation, talk to our team. Our monthly cost comparison sets out the self-funding arithmetic across every option.
The summary
Weight management is typically excluded from Pakistani health insurance as a lifestyle expense.
Complications of obesity are frequently covered while treating obesity is not, which is economically backwards.
A diabetes indication may be considered where a weight indication is not, which is why the same molecule carries two brand names.
No GLP-1 medication is registered in Pakistan, so even a theoretically covered claim usually has no practical route.
Ask about specific indications and request exclusions in writing rather than asking whether weight loss is covered.
Find out what the program costs if you are self-funding.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.